Endothelin receptor antagonist attenuates oxidative stress in a neonatal sepsis piglet model

Pediatric Research

Volumn 72, Issue 6, 2012, Pages 600-605

  Goto, Tatenobu ^a   Hussein, Mohamed Hamed ^a,b   Kato, Shin ^a   Daoud, Ghada Abdel Hamid ^b   Kato, Takenori ^a   Sugiura, Takahiro ^a   Kakita, Hiroki ^a   Nobata, Masanori ^a   Kamei, Michi ^a   Mizuno, Haruo ^a   Imai, Masaki ^a   Ito, Tetsuya ^a   Kato, Ineko ^a,c   Suzuki, Satoshi ^a   Okada, Noriko ^a   Togari, Hajime ^a   Okada, Hidechika ^a,d  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b EgyBlood ^*  (Egypt)

^c SAITAMA MEDICAL UNIVERSITY   (Japan)

^d Fukushimura Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; ANTISENSE OLIGONUCLEOTIDE; ASPARTATE AMINOTRANSFERASE; CREATININE; ENDOTHELIN RECEPTOR ANTAGONIST; ENDOTHELIN RECEPTOR P1 FL; HYDROPEROXIDE; INTERLEUKIN 6; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ANTISENSE THERAPY; ARTICLE; ARTIFICIAL VENTILATION; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTINUOUS INFUSION; CREATININE BLOOD LEVEL; EXPERIMENTAL PIG; NEWBORN; NEWBORN SEPSIS; NONHUMAN; OXIDATIVE STRESS; PIGLET; PRIORITY JOURNAL;

ANIMALS; ASPARTATE AMINOTRANSFERASES; CREATININE; HYDROGEN PEROXIDE; INTERLEUKIN-6; OXIDATIVE STRESS; PEPTIDES; RECEPTORS, ENDOTHELIN; SWINE;

EID: 84871336926     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1038/pr.2012.134     Document Type: Article

References (40)

1. Morise Z, Ueda M, Aiura K, Endo M, Kitajima M. Pathophysiologic role of endothelin-1 in renal function in rats with endotoxin shock. Surgery 1994;115:199-204.
2. Figueras-Aloy J, Gez-Lopez L, Rodru-Miguez JM, et al. Plasma endothelin-1 and clinical manifestations of neonatal sepsis. J Perinat Med 2004;32:522-6.
3. Rosenberg AA, Kennaugh J, Koppenhafer SL, Loomis M, Chatfield BA, Abman SH. Elevated immunoreactive endothelin-1 levels in newborn infants with persistent pulmonary hypertension. J Pediatr 1993;123:109-14.
4. Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988;332:411-5.
5. Sumner MJ, Cannon TR, Mundin JW, White DG, Watts IS. Endothelin ETA and ETB receptors mediate vascular smooth muscle contraction. Br J Pharmacol 1992;107:858-60.
6. de Nucci G, Thomas R, D'Orleans-Juste P, et al. Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc Natl Acad Sci USA 1988;85:9797-800.
7. Silveira RC, Procianoy RS. Evaluation of interleukin-6, tumour necrosis factor-alpha and interleukin-1beta for early diagnosis of neonatal sepsis. Acta Paediatr 1999;88:647-50.
8. Casey LC, Balk RA, Bone RC. Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med 1993;119:771-8.
9. Sullivan JS, Kilpatrick L, Costarino AT Jr, Lee SC, Harris MC. Correlation of plasma cytokine elevations with mortality rate in children with sepsis. J Pediatr 1992;120(4 Pt 1):510-5.
10. Saugstad OD. Mechanisms of tissue injury by oxygen radicals: implications for neonatal disease. Acta Paediatr 1996;85:1-4.
11. Buonocore G, Perrone S, Longini M, Terzuoli L, Bracci R. Total hydroperoxide and advanced oxidation protein products in preterm hypoxic babies. Pediatr Res 2000;47:221-4.
12. Dohi K, Satoh K, Ohtaki H, et al. Elevated plasma levels of bilirubin in patients with neurotrauma reflect its pathophysiological role in free radical scavenging. In Vivo 2005;19:855-60.
13. Baranyi L, Campbell W, Ohshima K, Fujimoto S, Boros M, Okada H. The antisense homology box: a new motif within proteins that encodes biologically active peptides. Nat Med 1995;1:894-901.
14. Baranyi L, Campbell W, Ohshima K, et al. Antisense homology box-derived peptides represent a new class of endothelin receptor inhibitors. Peptides 1998;19:211-23.
15. Szalay L, Kaszaki J, Nagy S, Boros M. The role of endothelin-1 in circulatory changes during hypodynamic sepsis in the rat. Shock 1998;10:123-8.
16. Goto T, Hussein MH, Kato S, et al. Endothelin receptor antagonist attenuates inflammatory response and prolongs the survival time in a neonatal sepsis model. Intensive Care Med 2010;36:2132-9.
17. Kakita H, Hussein MH, Daoud GA, et al. Total hydroperoxide and biological antioxidant potentials in a neonatal sepsis model. Pediatr Res 2006;60:675-9.
18. Hussein MH, Kato T, Sugiura T, et al. Effect of hemoperfusion using polymyxin B-immobilized fiber on IL-6, HMGB-1, and IFN gamma in a neonatal sepsis model. Pediatr Res 2005;58:309-14.
19. Kato T, Hussein MH, Sugiura T, et al. Development and characterization of a novel porcine model of neonatal sepsis. Shock 2004;21:329-35.
20. Schreck R, Rieber P, Baeuerle PA. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J 1991;10:2247-58.
21. Satriano JA, Shuldiner M, Hora K, Xing Y, Shan Z, Schlondorff D. Oxygen radicals as second messengers for expression of the monocyte chemoattractant protein, JE/MCP-1, and the monocyte colony-stimulating factor, CSF-1, in response to tumor necrosis factor-alpha and immunoglobulin G. Evidence for involvement of reduced nicotinamide adenine dinucleotide phosphate (NADPH)-dependent oxidase. J Clin Invest 1993;92:1564-71.
22. Fialkow L, Wang Y, Downey GP. Reactive oxygen and nitrogen species as signaling molecules regulating neutrophil function. Free Radic Biol Med 2007;42:153-64.
23. Hara K, Yamashita S, Fujisawa A, Ishiwa S, Ogawa T, Yamamoto Y. Oxidative stress in newborn infants with and without asphyxia as measured by plasma antioxidants and free fatty acids. Biochem Biophys Res Commun 1999;257:244-8.
24. Cancelier AC, Petronilho F, Reinke A, et al. Inflammatory and oxidative parameters in cord blood as diagnostic of early-onset neonatal sepsis: a case-control study. Pediatr Crit Care Med 2009;10:467-71.
25. Kato S, Hussein MH, Kakita H, et al. Edaravone, a novel free radical scavenger, reduces high-mobility group box 1 and prolongs survival in a neonatal sepsis model. Shock 2009;32:586-92.
26. Tilg H, Trehu E, Atkins MB, Dinarello CA, Mier JW. Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55. Blood 1994;83:113-8.
27. Huribal M, Kumar R, Cunningham ME, Sumpio BE, McMillen MA. Endothelin-stimulated monocyte supernatants enhance neutrophil superoxide production. Shock 1994;1:184-7.
28. Li L, Watts SW, Banes AK, Galligan JJ, Fink GD, Chen AF. NADPH oxidase-derived superoxide augments endothelin-1-induced venoconstriction in mineralocorticoid hypertension. Hypertension 2003;42:316-21.
29. Callera GE, Touyz RM, Teixeira SA, et al. ETA receptor blockade decreases vascular superoxide generation in DOCA-salt hypertension. Hypertension 2003;42:811-7.
30. Somers MJ, Mavromatis K, Galis ZS, Harrison DG. Vascular superoxide production and vasomotor function in hypertension induced by deoxycorticosterone acetate-salt. Circulation 2000;101:1722-8.
31. Landry DW, Oliver JA. The pathogenesis of vasodilatory shock. N Engl J Med 2001;345:588-95.
32. Verhaar MC, Strachan FE, Newby DE, et al. Endothelin-A receptor antagonist-mediated vasodilatation is attenuated by inhibition of nitric oxide synthesis and by endothelin-B receptor blockade. Circulation 1998;97:752-6.
33. Skalska AB, Pietrzycka A, Stepniewski M. Correlation of endothelin 1 plasma levels with plasma antioxidant capacity in elderly patients treated for hypertension. Clin Biochem 2009;42:358-64.
34. Handa O, Stephen J, Cepinskas G. Role of endothelial nitric oxide synthase-derived nitric oxide in activation and dysfunction of cerebrovascular endothelial cells during early onsets of sepsis. Am J Physiol Heart Circ Physiol 2008;295:H1712-9.
35. Eszli E, Czel M, Moln G, et al. Modulation of cardiac contractility through endothelin-1 release and myocardial mast cell degranulation. Acta Physiol Hung 2008;95:267-85.
36. Boros M, Szalay L, Kaszaki J. Endothelin-1 induces mucosal mast cell degranulation and tissue injury via ETA receptors. Clin Sci 2002;103:Suppl 48:31S-4S.
37. Kaszaki J, Czel M, Szalay L, Nagy S, Boros M. Endothelin-1 induces organ-specific histamine liberation and neutrophil granulocyte accumulation in the rat. Inflamm Res 2008;57:396-402.
38. Imai MM, Okada AA, Okada HH, et al. Rescue with an anti-inflammatory peptide of chickens infected H5N1 avian flu. Nature Precedings 2009. (http://hdl.handle.net/10101/npre.2009.3425.1.
39. Beghetti M, Haworth SG, Bonnet D, et al. Pharmacokinetic and clinical profile of a novel formulation of bosentan in children with pulmonary arterial hypertension: the FUTURE-1 study. Br J Clin Pharmacol 2009;68:948-55.
40. O'Brien WF, Golden SM, Davis SE, Bibro MC. Endotoxemia in the neonatal lamb. Am J Obstet Gynecol 1985;151:671-4.